Wholesale prices were up slightly in March but nothing too outstanding. Compared to a year ago, prices are seen down by 3.0%. That continues to underscore some easing in price pressures in the bigger picture at least.
Wholesale prices were up slightly in March but nothing too outstanding. Compared to a year ago, prices are seen down by 3.0%. That continues to underscore some easing in price pressures in the bigger picture at least.
Most Popular
Sponsored
NVDA's forward P/E of 25 beats S&P 500's 21.8, suggesting AI growth justifies its valuation.
CVLT dips 4.2% on hold rating; SNOW +3.4% on GPT 5.5. NVDA +3.6% on AI sentiment.
Biogen's Q1 revenue seen down 8.3% YoY. Last quarter beat, but peers up 11% while BIIB dips 3.9%.
HHH revenue down 36.5% despite beat, stock drops 20.9%. REAX revenue up 44.1% but stock down 26.2%.
FirstEnergy's Q1 earnings up 7.5% on infrastructure spend. Predictable returns via formula rates.
OXY's revenue fell 20.7%, missing estimates, yet its stock is up 21.5%. Peers saw mixed results, with E&P stocks up 11.7% avg.
Qatar offers 40% business support amid regional risks. IMF forecasts -8.6% GDP contraction.
Sponsored
Must Read